Paper16306358
Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes.
Rahmoune H and 5 others. Diabetes, 2005. Cited by 623 papers, by iCite.
Cite this record
ConductScience Library. Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes. Papers, record 16306358. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16306358
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus, Type 2 | Major topic |
| Glucose Transport Proteins, Facilitative | Major topic |
| Kidney Tubules, Proximal | Major topic |
| Urine | Major topic |
| Base Sequence | |
| Biological Transport | |
| DNA Primers | |
| Epithelial Cells | |
| Glucose | |
| Humans | |
| Microscopy, Confocal | |
| Polymerase Chain Reaction |
Source PubMed
Trials3
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT02798744 | SGLT-2 Inhibitor Empagliflozin Effects on Appetite and Weight Regulation. | Background | ClinicalTrials.gov | |
| NCT02887677 | Effects of Dapagliflozin on Central Hemodynamics and Urine Albumin Excretion in Patients With Type 2 Diabetes. | Background | ClinicalTrials.gov | |
| NCT05727423 | Dapagliflozin in the Treatment of Heart Failure | Background | ClinicalTrials.gov |
Cited by319
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 623 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42927000 | A Cost-Effective, Kit-Free Method for Extracting Nuclear and Mitochondrial DNA From Low-Abundance Cells in Urine Samples. | Cureus | 2026 | https://conductscience.org/library/papers/42927000 | PubMed |
| 42418090 | Renal glucose metabolic enzyme expression during AKI-to-CKD transition. | Int Urol Nephrol | 2026 | https://conductscience.org/library/papers/42418090 | PubMed |
| 42009842 | Salt and chronic kidney disease. | Nat Rev Nephrol | 2026 | https://conductscience.org/library/papers/42009842 | PubMed |
| 41930239 | Treatment of Youth-Onset Type 2 Diabetes: Focus on SGLT-2 Inhibitor Use. | Pediatr Diabetes | 2026 | https://conductscience.org/library/papers/41930239 | PubMed |
| 41550024 | Imbalance of mitochondria and abnormalities in lipid metabolism in Diabetic Tubulopathy. | Ann Med | 2026 | https://conductscience.org/library/papers/41550024 | PubMed |
| 41323303 | "Sweating Kidneys" refers to perirenal effusion as a complication of SGLT2i: A case reports. | Urol Case Rep | 2026 | https://conductscience.org/library/papers/41323303 | PubMed |
| 41301689 | Complementary Yet Distinct Roles of GLP-1 Receptor Agonists and SGLT2 Inhibitors in Cardiovascular Risk Reduction. | Biomedicines | 2025 | https://conductscience.org/library/papers/41301689 | PubMed |
| 41163811 | Estimated Glomerular Filtration Rate and Incident Prediabetes Risk in Normoglycemic Adults With Parental Type 2 Diabetes. | J Endocr Soc | 2025 | https://conductscience.org/library/papers/41163811 | PubMed |
| 41009421 | Thyroid Hormones Regulate Postprandial Glucose Metabolism by Regulating SGLT1 Expression in the Small Intestine in Rats and Mice. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41009421 | PubMed |
| 40943149 | Diabetic Kidney Disease: From Pathophysiology to Regression of Albuminuria and Kidney Damage: Is It Possible? | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40943149 | PubMed |
| 40928723 | A review of the effect of SGLT2 inhibitors on clinical and glycemic outcomes in hospitalized patients: data from studies that included patients with diabetes. | Hormones (Athens) | 2026 | https://conductscience.org/library/papers/40928723 | PubMed |
| 40926738 | An SGLT2 inhibitor, canagliflozin, reduces blood glucose level in the renal capillaries and protects the capillary network in the diabetic rats. | Diabetes Obes Metab | 2025 | https://conductscience.org/library/papers/40926738 | PubMed |
| 40564143 | Pathogenesis and Therapeutic Perspectives of Tubular Injury in Diabetic Kidney Disease: An Update. | Biomedicines | 2025 | https://conductscience.org/library/papers/40564143 | PubMed |
| 40540353 | Noninvasive Assessment of Urinary Exfoliated Proximal Tubule Cell Multispectral Autofluorescence May Differentiate between Causes of Kidney Transplant Dysfunction. | Kidney360 | 2025 | https://conductscience.org/library/papers/40540353 | PubMed |
| 40445480 | D-Glucose and its derivatives labeled with radioactive carbon and hydrogen: key tools for investigating biological processes and molecular mechanisms. | EJNMMI Radiopharm Chem | 2025 | https://conductscience.org/library/papers/40445480 | PubMed |
| 40411658 | The Role of Diabetes and SGLT2 Inhibitors in Cerebrovascular Diseases. | Curr Neurol Neurosci Rep | 2025 | https://conductscience.org/library/papers/40411658 | PubMed |
| 40349958 | Epigallocatechin gallate prevents and alleviates type 2 diabetes mellitus (T2DM) through gut microbiota and multi-organ interactions in Wistar healthy rats and GK T2DM rats. | J Adv Res | 2026 | https://conductscience.org/library/papers/40349958 | PubMed |
| 40302966 | Efficacy and Safety of SGLT2 Inhibitors in Pediatric Patients and Young Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. | Pediatr Diabetes | 2024 | https://conductscience.org/library/papers/40302966 | PubMed |
| 40208690 | Coordinated Regulation of Renal Glucose Reabsorption and Gluconeogenesis by mTORC2 and Potassium. | J Am Soc Nephrol | 2025 | https://conductscience.org/library/papers/40208690 | PubMed |
| 40164842 | [Effects of "new" antidiabetic drugs on management of anesthesia]. | Anaesthesiologie | 2025 | https://conductscience.org/library/papers/40164842 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ANPEP | 290 | PubTator's text mining | https://conductscience.org/library/genes/290 | NCBI Gene |
| SLC2A2 | 6514 | PubTator's text mining | https://conductscience.org/library/genes/6514 | NCBI Gene |
| SLC5A2 | 6524 | PubTator's text mining | https://conductscience.org/library/genes/6524 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16306358
GET https://conductscience.org/api/papers/v1/16306358/cited_by?page=2